AH13205 structure
|
Common Name | AH13205 | ||
---|---|---|---|---|
CAS Number | 148436-63-9 | Molecular Weight | 388.54000 | |
Density | 1.075g/cm3 | Boiling Point | 574.1ºC at 760mmHg | |
Molecular Formula | C24H36O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 315.1ºC |
Use of AH13205AH13205 is an EP2 prostanoid receptor agonist. |
Name | trans-2-(4-(1-Hydroxyhexyl)phenyl-5-oxocyclopentaneheptanoic acid |
---|---|
Synonym | More Synonyms |
Density | 1.075g/cm3 |
---|---|
Boiling Point | 574.1ºC at 760mmHg |
Molecular Formula | C24H36O4 |
Molecular Weight | 388.54000 |
Flash Point | 315.1ºC |
Exact Mass | 388.26100 |
PSA | 74.60000 |
LogP | 5.78820 |
Vapour Pressure | 5.06E-14mmHg at 25°C |
Index of Refraction | 1.528 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
New reagent system for attaining high regio- and stereoselectivities in allylic displacement of 4-cyclopentene-1,3-diol monoacetate with aryl- and alkenylmagnesium bromides.
Org. Lett. 7(2) , 183-6, (2005) [Reaction: see text] Low regioselectivity of RMgBr (R = aryl, alkenyl) in the CuCN-catalyzed reaction with 4-cyclopentene-1,3-diol monoacetate is improved by addition of LiCl or MgCl2 to a similar ext... |
|
Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration.
Molecular Neurodegeneration 5 , 13, (2010) An early event in the neuropathology of prion and Alzheimer's diseases is the loss of synapses and a corresponding reduction in the level of synaptophysin, a pre-synaptic membrane protein essential fo... |
|
EP4 receptor as a new target for bronchodilator therapy.
Thorax 66(12) , 1029-35, (2011) Asthma and chronic obstructive pulmonary disease are airway inflammatory diseases characterised by airflow obstruction. Currently approved bronchodilators such as long-acting β(2) adrenoceptor agonist... |
7-[(1R,2S)-2-[4-(1-hydroxyhexyl)phenyl]-5-oxocyclopentyl]heptanoic acid |